StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Inventory & Laboratory Sequencing Materials Purchase by Year

Inventory & Laboratory Sequencing Materials Purchase Obligations ($M) ($M)

Natera Inventory & Laboratory Sequencing Materials Purchase: $107M in FY2025, up 98.8% from a year earlier.

Latest, FY2025
107
Period ended Dec 31, 2025
Change on a year earlier
+98.8%
54.0 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Non-cancelable purchase commitments for Illumina sequencing consumables, reagents, and laboratory supplies.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInventory & Laboratory Sequencing Materials Purchase Obligations ($M) ($M)Year on yearSource
FY2025Dec 31, 2025107+98.8%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 202454.0+160.7%Form 10-K (2025-02-28) ↗
FY2023Dec 31, 202320.7+32.2%Form 10-K (2024-02-29) ↗
FY2022Dec 31, 202215.7-2.4%Form 10-K (2023-03-01) ↗
FY2021Dec 31, 202116.0-7.2%Form 10-K (2022-02-25) ↗
FY2020Dec 31, 202017.3–Form 10-K (2021-02-26) ↗

Cite this data

StockData. (2026). Natera Inventory & Laboratory Sequencing Materials Purchase ($M), annual FY2020–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/purchase-oblig-inventory-materials

See every metric in the Natera KPI table. Data updated Nov 2, 2026.